🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This phase II study is a randomized, placebo-controlled, double-blind study...
Status
Recruiting
Location
Taipei Medical University-Shuang Ho Hospital,Ministry of Health and Welfare
Start Date
2024-06-11
Trial ID
NCT06491043
Treatments Being Tested
The study aims to determine the effectiveness on the tear film quality and ...
Status
Unknown
Location
Plava Medical Group
Start Date
2023-03-25
Trial ID
NCT05825976
Treatments Being Tested
Noradrenaline is a catecholamine and the cornerstone treatment for the impr...
Status
Completed
Location
Radboudumc
Start Date
2016-01
Trial ID
NCT02675868
Treatments Being Tested
This study is being performed to comply with regulatory requirements that a...
Status
Completed
Location
GSK Investigational Site
Start Date
2014-11-17
Trial ID
NCT02293148
Explore the clinical efficacy of 7-day treatment regimens of guaifenesin in...
Status
Completed
Location
Med Investigations
Start Date
2012-02
Trial ID
NCT01562548
Treatments Being Tested
The primary objective of this study is to evaluate the safety, tolerability...
Status
Completed
Location
ICON Development Solutions
Start Date
2014-07
Trial ID
NCT02211625
Treatments Being Tested
The objective of this trial is to evaluate the pharmacodynamics, pharmacoki...
Status
Completed
Location
1245.15.003 Boehringer Ingelheim Investigational Site
Start Date
2009-04
Trial ID
NCT00885118
This is a multicenter study to test the hypothesis that suvorexant (MK-4305...
Status
Completed
Location
Multiple Locations
Start Date
2010-05-05
Trial ID
NCT01097616
Treatments Being Tested
This is a randomized, double blind, placebo and active (moxifloxacin open l...
Status
Completed
Location
Celerion, Inc.
Start Date
2023-07-11
Trial ID
NCT05927649
Treatments Being Tested
Double blind, randomized, placebo controlled, Phase 3 study to investigate ...
Status
Completed
Location
Children's Hospital Los Angeles
Start Date
2018-05-16
Trial ID
NCT03566238
Treatments Being Tested